EnzySurge

EnzySurge Ltd. is a developer and provider of innovative solutions for the treatment and management of chronic wounds. The company was founded in 2001 by Professor Amihay Freeman of Tel Aviv University. EnzySurge's flagship product, the DermaStream® platform, is based on proprietary Continuous Streaming Therapy (CST) technology, offering a novel and unique wound treatment method by continuously delivering fresh advanced bioactive treatment solutions to a controlled wound environment. DermaStream® is designed to provide effective, cost-efficient, and easy-to-use wound treatment across all stages of the chronic wound healing cycle, from debridement and regeneration to wound closure. DermaStream is suitable for use in hospitals, clinics, nursing homes, and home care.